1. A Bayesian Framework Allowing Incorporation of Retrospective Information in Prospective Diagnostic Biomarker-Validation Designs. (3rd July 2019) Authors: Barrado, Leandro García; Coart, Els; Burzykowski, Tomasz Journal: Statistics in biopharmaceutical research Issue: Volume 11:Number 3(2019) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses. (January 2019) Authors: Rotolo, Federico; Paoletti, Xavier; Burzykowski, Tomasz; Buyse, Marc; Michiels, Stefan Journal: Statistical methods in medical research Issue: Volume 28:Number 1(2019) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An information‐theoretic approach for the evaluation of surrogate endpoints based on causal inference. Issue 3 (10th February 2016) Authors: Alonso, Ariel; Van der Elst, Wim; Molenberghs, Geert; Buyse, Marc; Burzykowski, Tomasz Journal: Biometrics Issue: Volume 72:Issue 3(2016) Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bayesian biomarker-driven outcome-adaptive randomization with an imperfect biomarker assay. (April 2021) Authors: Garcia Barrado, Leandro; Burzykowski, Tomasz Journal: Clinical trials Issue: Volume 18:Number 2(2021) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology. (4th December 2021) Authors: Goldberg, Richard M; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; André, Thierry; Sobrero, Alberto F; Lichtman, Stuart M; Benson, Al B; Punt, Cornelis J A; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, ... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 6(2022) Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Computational methods and challenges in hydrogen/deuterium exchange mass spectrometry. Issue 5 (7th September 2016) Authors: Claesen, Jürgen; Burzykowski, Tomasz Other Names: Valkenborg Dirk guestEditor. Journal: Mass spectrometry reviews Issue: Volume 36:Issue 5(2017:Sep./Oct.) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. De novo prediction of the elemental composition of peptides and proteins based on a single mass. (13th August 2019) Authors: Claesen, Jürgen; Valkenborg, Dirk; Burzykowski, Tomasz Journal: Journal of mass spectrometry Issue: Volume 55:Number 8(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring. (October 2019) Authors: Trotta, Laura; Kabeya, Yuusuke; Buyse, Marc; Doffagne, Erik; Venet, David; Desmet, Lieven; Burzykowski, Tomasz; Tsuburaya, Akira; Yoshida, Kazuhiro; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi; Praveen, Paurush; Oba, Koji Journal: Clinical trials Issue: Volume 16:Number 5(2019) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference test. (21st September 2015) Authors: García Barrado, Leandro; Coart, Els; Burzykowski, Tomasz Journal: Statistics in medicine Issue: Volume 35:Number 4(2016) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis. Issue 3 (March 2019) Authors: Saad, Everardo D; Squifflet, Pierre; Burzykowski, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P; Slamon, Dennis; Wolmark, Norman; Buyse, Marc Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗